Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Cornea and External Disease
When should mitomycin intravascular chemoembolization be considered as a treatment for corneal neovascularization?
Related Questions
What has been your experience with netarsudil in the management of corneal edema, particularly concerning its clinical effectiveness and insurance coverage?
How does LAL+ compare with other EDOF lenses?
How do you approach IOL exchange in a patient who is unhappy after cataract surgery with a premium IOL?
In patients with corneal edema and a glaucoma drainage tube placed in the AC, under what circumstances would you consider repositioning the tube in the sulcus first versus proceeding directly with endothelial keratoplasty alone?
How do you predict which patients are most likely to have a positive response to Oxervate?
In cataract surgery following penetrating keratoplasty, do you think the use of scleral tunnel incisions versus clear corneal incisions meaningfully influence graft survival or astigmatic stability?
How do you manage a situation where the lens optic shifts in front of the iris after a Yamane technique?
How do you decide who would be a candidate for a prosthetic iris implant and what pre-op evaluation or testing do you do?
When do you decide to proceed with cataract or glaucoma surgery in patients with non-quiescent herpetic stromal keratitis?
What is your approach to incorporating IPL therapy for meibomian gland dysfunction?
